Trillium Therapeutics Inc (TRIL)

8.16
-0.12(-1.45%)
  • Volume:
    93,460
  • Bid/Ask:
    8.14/8.16
  • Day's Range:
    8.02 - 8.43
  • Type:Equity
  • Market:Canada
  • ISIN:CA89620X5064
  • CUSIP:89620X506

TRIL Overview

Prev. Close
8.28
Day's Range
8.02-8.43
Revenue
192.24K
Open
8.21
52 wk Range
8.02-27.12
EPS
-0.74
Volume
93,460
Market Cap
841.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
137,572
P/E Ratio
-
Beta
1.81
1-Year Change
-8.42%
Shares Outstanding
103,137,173
Next Earnings Date
Aug. 06, 2021
What is your sentiment on Trillium Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Trillium Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellSell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell

Trillium Therapeutics Inc Company Profile

Trillium Therapeutics Inc Company Profile

Employees
0
Market
Canada

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.